- Journal
- EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
- Année
- 2024
- Volume
- 31
- Numéro
- 15, SI
- Pages
- 1850-1860
- Mois
- AUG 28
- DOI
- 10.1093/eurjpc/zwae255
Abstract
Lipid-lowering therapy (LLT) is under-prescribed in women after acute myocardial infarction (AMI). Whether this difference persists over time and influences long-term outcomes is unclear. Women still suffer from insufficient prescription of high-intensity LLT at discharge after an AMI, even in the most recent years of the study, with a 5 year survival significantly reduced in women who did not receive high-dose LLT Propensity score matched analysis showed similar results on survival and cardiovascular events.